天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Dolutegravir Impurity C

Dolutegravir Impurity C Struktur
1802141-49-6
CAS-Nr.
1802141-49-6
Englisch Name:
Dolutegravir Impurity C
Synonyma:
Durutevir impurity 23;Dolutegravir Impurity 20;Dolutegravir Impurity 23;Dolutegravir Impurity 32;Syringaresinol Impurity 1(Syringaresinol Diglucoside);(4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1,2:;(4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-7-ethoxy-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-, (4R,12aS)-
CBNumber:
CB96222324
Summenformel:
C22H23F2N3O5
Molgewicht:
447.43
MOL-Datei:
1802141-49-6.mol

Dolutegravir Impurity C Eigenschaften

Siedepunkt:
688.1±55.0 °C(Predicted)
Dichte
1.42±0.1 g/cm3(Predicted)
pka
10.71±0.40(Predicted)

Sicherheit

Dolutegravir Impurity C Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

O-Ethyl Dolutegravir is an impurity of Dolutegravir (D528800), which is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.

Dolutegravir Impurity C Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Dolutegravir Impurity C Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangzhou Jiuzhi Pharmaceutical Technology Co., Ltd. 020-89854820
sales@jzpharma.cn China 1247 58
Molcoo Chemicals Inc. 18576690171
3001025734@qq.com China 9228 58
Shenzhen Roark Pharma-Tec Co., Ltd. 13128912434
2880126944@qq.com China 2869 58
HX Pharmaceutical technology co., LTD 15671363360
494267389@qq.com China 4138 58
guoyungurui 18162595016; 18162595016
3287908757@qq.com China 10335 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 13986652530
zhangweiyue@hdimpurity.com China 7843 58
Hubei Moco Chemical Co., Ltd. 18627753421; 18627756402
3001051413@qq.com China 19375 58

  • Dolutegravir Impurity 20
  • (4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1,2:
  • Dolutegravir Impurity 23
  • (4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
  • 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-7-ethoxy-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-, (4R,12aS)-
  • Dolutegravir Impurity 32
  • Syringaresinol Impurity 1(Syringaresinol Diglucoside)
  • Durutevir impurity 23
  • 1802141-49-6
Copyright 2019 ? ChemicalBook. All rights reserved